$Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study$

Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study

Abstract Background Consolidative allogeneic hematopoietic stem cell transplantation is a controversial option for patients with relapsed/refractory acute lymphoblastic leukemia after chimeric antigen receptor T cell (CAR-T) therapy. We performed a multicenter retrospective study to assess whether p...

Full description

Bibliographic Details
Main Authors:	Houli Zhao, Jieping Wei, Guoqing Wei, Yi Luo, Jimin Shi, Qu Cui, Mingfeng Zhao, Aibin Liang, Qing Zhang, Jianmin Yang, Xin Li, Jing Chen, Xianmin Song, Hongmei Jing, Yuhua Li, Siguo Hao, Wenjun Wu, Yamin Tan, Jian Yu, Yanmin Zhao, Xiaoyu Lai, Elaine Tan Su Yin, Yunxiong Wei, Ping Li, Jing Huang, Tao Wang, Didier Blaise, Lei Xiao, Alex H. Chang, Arnon Nagler, Mohamad Mohty, He Huang, Yongxian Hu
Format:	Article
Language:	English
Published:	BMC 2020-05-01
Series:	Journal of Hematology & Oncology
Subjects:	Chimeric antigen receptor T cell therapy Haploidentical hematopoietic stem cell transplantation Leukemia-free survival Minimal residual disease negativity Overall survival Relapsed/refractory acute lymphoblastic leukemia
Online Access:	http://link.springer.com/article/10.1186/s13045-020-00873-7

Similar Items

Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data
by: Sijian Yu, et al.
Published: (2020-03-01)

Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT
by: Simona Piemontese, et al.
Published: (2019-07-01)

Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study
by: Ying-Jun Chang, et al.
Published: (2020-03-01)

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
by: Nicole Santoro, et al.
Published: (2017-05-01)

Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT
by: Nicole Santoro, et al.
Published: (2018-04-01)

Increased risk of 100-day and 1-year infection-related mortality and complications in haploidentical stem cell transplantation
by: Chang J, et al.
Published: (2019-05-01)

Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation
by: Susanne H. C. Baumeister, et al.
Published: (2020-02-01)

Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
by: Arnon Nagler, et al.
Published: (2021-04-01)

Preventive Use of Azacitidine in Patients with Acute Myeloid Leukemia after Haploidentical Allo-BMT
by: RSh Badaev, et al.
Published: (2018-12-01)

Haploidentical hematopoietic stem cell transplantation without total body irradiation for pediatric acute leukemia: a single-center experience
by: Mu YS, et al.
Published: (2016-05-01)

Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia
by: Li-Ping Dou, et al.
Published: (2018-01-01)

The Evolution of T Cell Depleted Haploidentical Transplantation
by: Franco Aversa, et al.
Published: (2019-11-01)

Impact of Donor-Specific anti-HLA antibodies and donor KIR characteristics in haploidentical HSCT for beta-Thalassemia
by: Marco Andreani, et al.
Published: (2017-03-01)

Clinical significance of the achievement of MRD-negativity in patients with chronic lymphocytic leukemia
by: Yu V Mirolyubova, et al.
Published: (2018-03-01)

Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT
by: Jaime Sanz, et al.
Published: (2020-05-01)

Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT
by: Jaime Sanz, et al.
Published: (2021-05-01)

Molecular monitoring of minimal residual disease in two patients with <it>MLL</it>-rearranged acute myeloid leukemia and haploidentical transplantation after relapse
by: Burmeister Thomas, et al.
Published: (2012-04-01)

Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantation
by: Hejin Jia, et al.
Published: (2019-06-01)

Haploidentical Stem Cell Transplantation in Lymphomas—Expectations and Pitfalls
by: Jacopo Mariotti, et al.
Published: (2020-11-01)

The Role of Measurable Residual Disease (MRD) in Hematopoietic Stem Cell Transplantation for Hematological Malignancies Focusing on Acute Leukemia
by: Anna Czyz, et al.
Published: (2019-10-01)

Haploidentical Stem Cell Transplantation in Children With Hematological Malignancies Using αβ+ T-Cell Receptor and CD19+ Cell Depleted Grafts: High CD56dim/CD56bright NK Cell Ratio Early Following Transplantation Is Associated With Lower Relapse Incidence and Better Outcome
by: Miguel A. Diaz, et al.
Published: (2019-10-01)

Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine
by: Federica Giannotti, et al.
Published: (2018-08-01)

G-CSF-Primed Peripheral Blood Stem Cell Haploidentical Transplantation Could Achieve Satisfactory Clinical Outcomes for Acute Leukemia Patients in the First Complete Remission: A Registered Study
by: Yan-Ru Ma, et al.
Published: (2021-03-01)

Serum 25-Hydroxyvitamin D Levels and Prognosis in Hematological Malignancies: A Systematic Review and Meta-Analysis
by: Wei Wang, et al.
Published: (2015-03-01)

ACUTE LYMPHOBLASTIC LEUKEMIA WITH PANCYTOPENIA AT PRESENTATION: CLINICAL CORRELATES, PROGNOSTIC IMPACT AND ASSOCIATION WITH SURVIVAL.
by: Ketan Kulkarni, et al.
Published: (2014-08-01)

Long-term and quality of survival in patients treated for acute lymphoblastic leukemia during the pediatric age
by: Lara Devilli, et al.
Published: (2021-03-01)

A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation
by: Chen, H., et al.
Published: (2022)

Haploidentical related donor vs matched sibling donor allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome aged over 50 years: A single‐center retrospective study
by: Jiafu Huang, et al.
Published: (2020-09-01)

Comparisons Between Frontline Therapy and a Combination of Eltrombopag Plus Immunosuppression Therapy and Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Systematic Review
by: Yuan Yang, et al.
Published: (2021-04-01)

Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis
by: Ying-Jun Chang, et al.
Published: (2017-07-01)

Resolution of bone, cutaneous, and muscular involvement after haploidentical hematopoietic stem cell transplantation followed by post‐transplant cyclophosphamide in adult T‐cell leukemia/lymphoma
by: Futoshi Iioka, et al.
Published: (2020-08-01)

Survival Rate of Patients with Acute Leukemia: A Case Study in Iran
by: Mohammad Ranjbar, et al.
Published: (2020-12-01)

Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
by: Samuel Cytryn, et al.
Published: (2020-04-01)

Peripheral blood lymphocyte responses to cytomegalovirus seropositivity after allogeneic-hematopoietic stem cell transplantation
by: Zhang J, et al.
Published: (2018-08-01)

Survival Rate and Associated Factors of Childhood Leukemia in Iran: A Systematic Review and Meta Analysis
by: Yousef Veisani, et al.
Published: (2017-07-01)

Real‐world data of chronic myelomonocytic leukemia: A chinese single‐center retrospective study
by: Liya Ma, et al.
Published: (2021-03-01)

TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia
by: Sixuan Qian, et al.
Published: (2016-11-01)

Comparison of CNS Relapse, Survival and Intelligent Quotient in Non-High Risk ALL Children Treated with Intrathecal Methotrexate or Triple Intrathecal Therapy
by: Nahid Raeissi, et al.
Published: (2019-08-01)

Features of Childhood Acute Myeloid Leukemia in Iran: a Report from Double Center Study
by: Azim Mehrvar, et al.
Published: (2015-12-01)

5-year survival rate based on the types of leukemia in Iran: a Meta-analysis
by: Yousef Veisani, et al.
Published: (2018-09-01)